This year the journal underwent critical leadership changes that build on the outstanding successes of our past editors, Drs. George Beller and Barry Zaret. Both of our prior editors created their own unique imprint on the field of nuclear cardiology focusing on high quality, high impact manuscripts that have led our field to be one of the most commonly used diagnostic procedures from around the world. We owe both of these prior editors a tremendous debt of gratitude for their commitment to the field, their vision for the journal, and their leadership in creating a very high quality journal. Recently, Dr. Ami Iskandrian assumed the role of editor-in-chief of the journal and, under his leadership; a new vision for the journal will unfold and new concepts will be implemented that will further enhance what we believe will be the clinical and scientific value of research achievements and evidence synthesis in the field of nuclear cardiology. Dr. Iskandrian's team of key leaders in the field represent the far reaching areas within nuclear cardiology that can judge and guide aspects of the journal toward a high level of clinical, technical, and research achievements.
Those of you who know Dr. Iskandrian understand that he is a man in motion, full of life, and abounding with new ideas that we hope will re-shape our journal to meet the needs of our dramatically changing clinical and research environment that is facing our readers and members of ASNC. Our current editor-in-chief abounds with evolutionary ideas on how to improve the journal and we eagerly anticipate the next few months to years to see the fruition of these ''outside of the box'' concepts that may be implemented in the journal.
Importantly, our journal is not stagnant but continues to undergo member-guided revisions that we believe can help to target publications that will be value-added to your ASNC membership. Our journal has weathered significant challenges over the past few years with the addition and increasing competition from new cardiovascular imaging journals. Yet, one fact is certain; the Journal of Nuclear Cardiology Ò remains the leading source of state-of-the art nuclear cardiology research and reviews. In the future, we will look to the journal for a greater understanding of how nuclear cardiology fits within our multimodality world and how we can target novel research developments to appropriately and safely grow the field. This journal no longer sits solely within the silo of ASNC and its members that focus only on expanding their referrals and utilization of nuclear cardiology. The group of editors and editorial board members will seek to engage the clinical and technical community to drive the focus of the journal while understanding new developments not only in nuclear cardiology but in other diagnostic imaging areas. The knowledge base required to not only maneuver within our multimodality world but to optimally guide clinical decision making is quite diverse and much more expansive than in decades past. Safety issues now have a greater prominence within nuclear cardiology when compared to other modalities that do not expose patients to ionizing radiation. Comparative accuracy and effectiveness are also of primary importance for imagers and the field in order to optimally drive coverage decisions and appropriate utilization patterns. Speaking for the journal's new leadership team, we look forward to the challenge and meeting the needs of our community with novelty, vision, and practicality to move our field and to garner a pathway for our future of nuclear cardiology in the decades to come.
